Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

Eli Lilly LLY is set to release its first-quarter earnings report on May 1. Here’s Morningstar’s take on what to look for in ...

This is partly thanks to Zepbound, a weight loss medicine that's already generating more than $1 billion in quarterly sales, although it was approved only in late 2023. Zepbound's prospects still ...

If they were serious about this goal, they would start by overhauling something they long have championed: Medicare Advantage. The program, in which private insurers oversee older people’s ...

The company's shares are down roughly 34 percent so far this year following major supply line disruptions pushing physicians to prescribe Eli Lilly's tirzepatide-based injection drugs Zepbound and ...

If they try to sleep outdoors in Brainerd or Baxter, which also criminalized encampments last year, they can face up to 90 days in jail and a $1,000 fine. The new ordinances were passed after a ...

President Donald Trump is swearing in Dr. Mehmet Oz as the 17th Centers for Medicare and Medicaid Services Administrator. The ceremony will begin at noon. Oz was confirmed for the position by the ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Orforglipron uses the same GLP-1 mechanism as weight-loss and diabetes injectables such as Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Zepbound and Mounjaro. David Ricks, Eli Lilly’s ...

Zepbound is used for weight loss or obstructive sleep apnea (OSA) in certain adults. Zepbound is a liquid solution that comes in two forms: prefilled, single-dose injector pens single-dose vials ...

(Ivanhoe Newswire) --- Obstructive sleep apnea or OSA affects nearly a billion ... also known as Mounjaro or Zepbound. “It's called GLP one receptor,” said Atul Malhotra, MD from the UC ...